| Press Release - | VNA and PCAS Market to Reach Valuation of 4728.19 USD Million by 2028; Rising Government Regulations and Positive Guidelines is Impacting the Growth of VNA and PCAS Market |
Vantage Market Research | 16 Mar 2022
VNA and PCAS Market to Reach Valuation of 4728.19 USD Million by 2028; Rising Government Regulations and Positive Guidelines is Impacting the Growth of VNA and PCAS Market

In terms of revenue, the Global VNA and PCAS Market is expected to reach 4728.19 USD Million by 2028, growing at a CAGR of 5.50% from 2022 to 2028.
The major driving factor is the presence of favorable government regulations for VNA and PCAS Markets and the increasing demand for standard-based storage, disaster recovery, and lifecycle management solutions are fueling the growth of the market for VNAs. Consolidation of patient information by integrating VNAs with electronic health records (EHR) is one of the important trends witnessed in the VNA and PCAS Market. VNA provides the healthcare sector to migrate from one vendor to another without worrying about imaging data loss. PACS is more focused on improving the workflow with an emphasis on the storage and retrieval of healthcare data.
Key Findings:
Some of key players in VNA and PCAS Market include, Novarad Corporation (U.S.), Koninklijke Philips N.V. (Netherlands), INFINITT Healthcare Co., Ltd. (South Korea), Siemens Healthineers AG (Germany), Hyland Software, Inc. (U.S.), Agfa-Gevaert Group (U.S.), GE Company (U.S.), Mach7 Technologies (U.S.), FUJIFILM Holdings Corporation (Japan), BridgeHead Software Ltd. (U.K.), IBM Corporation (U.S.), Sectra AB (Sweden), ASPYRA, LLC (U.S.), and Change Healthcare Inc. (U.S.),.
Vendor Neutral Archive (VNA) allows planning and managing the lifecycle of the medical stored files efficiently. PACS electronically stores images in the form of data in the files. With increasing cases of diseases, diagnostics in the healthcare sector is growing rapidly. The use of digital platforms for analyzing diseases is generating huge potential for diagnosing viruses and novel diseases. The growing number of medical imaging technologies along with geriatric imaging volumes is expected to generate revenue for the VNA and PCAS Market. However, the huge cost of diagnostics is one of the hindering factors for the growth of the market in the forecast period.
North America is expected to dominate the global VNA and PCAS Market in 2021 and is likely to continue the same trend during the forecast period. An increase in government initiatives and support in the healthcare industry is likely to generate demand in this region for this market in near future. An increase in R&D for developing new techniques in VNA and PACS in the healthcare industry in countries such as U.S. & Canada are further adding spotlight. Significant improvements in the clinical infrastructure, especially in the developing economies, are providing a thrust to the VNA and PCAS Market growth.
About Vantage Market Research:
We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.
VNA and PCAS Market to Reach Valuation of 4728.19 USD Million by 2028; Rising Government Regulations and Positive Guidelines is Impacting the Growth of VNA and PCAS Market
16 Mar 2022
Min Read
Access Full Report
VNA and PCAS Market to Reach Valuation of 4728.19 USD Million by 2028; Rising Government Regulations and Positive Guidelines is Impacting the Growth of VNA and PCAS Market
This report by Vantage Market Research delivers comprehensive analysis of Somatostatin Analogs Market , focusing on Market Size, Share & Trends Analysis Report by Type (Octreotide, Lanreotide, Pasireotide) by Application (Acromegaly, Neuroendocrine Tumors (NETs), Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Request SampleLatest Press Release
Contact
Toll Free Number+1 (877) 462-2282